Daily life ischemia and nitrate therapy

Area of Science:

• Cardiology
• Pharmacology

Background:

• Daily life ischemia, often silent, increases adverse outcome risk.
• Coronary vasomotion and myocardial oxygen demand are key in ischemia pathogenesis.
• Nitrate therapy is a rational treatment approach for daily life ischemia.

Purpose of the Study:

• To review the efficacy of nitrate therapy in managing daily life ischemia.
• To evaluate the impact of various nitrate formulations and dosing strategies on ischemic episodes.
• To identify the need for further research into optimal nitrate therapy for daily life ischemia.

Main Methods:

• Review of existing studies on sublingual, intravenous, oral, and transdermal nitroglycerin.
• Analysis of open-label uncontrolled observations and randomized, double-blind, placebo-controlled trials.
• Examination of data on ischemia frequency, duration, and development of tolerance.

Main Results:

• Sublingual nitroglycerin reduced both silent and painful ischemic episodes in effort angina.
• Isosorbide dinitrate/mononitrate decreased ischemic episodes in unstable and severe angina.
• Transdermal nitroglycerin studies yielded mixed results regarding efficacy and tolerance, with some suggesting reduced ischemia and others indicating tolerance development.

Conclusions:

• Nitrate therapy, particularly nitroglycerin, shows potential in reducing daily life ischemia.
• Conflicting results on tolerance and efficacy necessitate further large-scale controlled trials.
• Low-dose, intermittent topical nitrate therapy may be a promising strategy for daily life ischemia management.